| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Srinivas Akkaraju | Director | 2025-10-06 | 13,748 | $39.52 | $543.32kBuy |
| Srinivas Akkaraju | Director | 2025-10-06 | 18,414 | $37.89 | $697.71kBuy |
| Srinivas Akkaraju | Director | 2025-10-06 | 80,863 | $38.68 | $3.13MBuy |
| Srinivas Akkaraju | Director | 2025-10-03 | 56,703 | $36.74 | $2.08MBuy |
| Srinivas Akkaraju | Director | 2025-10-03 | 11,011 | $35.61 | $392.10kBuy |
| Srinivas Akkaraju | Director | 2025-10-03 | 319,700 | $37.42 | $11.96MBuy |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2025-09-22 | 3,353 | $30.67 | $102.85kSell |
| Katie Peng | Director | 2025-09-16 | 76 | $33.20 | $2.52kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2025-09-16 | 3,178 | $33.52 | $106.53kSell |
| Katie Peng | Director | 2025-09-16 | 930 | $32.48 | $30.20kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Srinivas Akkaraju | 16.68% | 16,036,105 | $474.99M | Insider |
| Fmr LLC | 14.39% | 13,834,875 | $409.79M | Institution |
| Siren LLC | 11.71% | 11,259,438 | $333.50M | Insider |
| Siren LLC | 9.62% | 9,250,005 | $273.99M | Institution |
| Invus Public Equities LP | 9.62% | 9,250,005 | $273.99M | Insider |
| Price T Rowe Associates Inc | 9.11% | 8,761,650 | $259.52M | Institution |
| Samsara Biocapital GP LLC | 7.06% | 6,788,609 | $201.08M | Insider |
| Blackrock Inc | 6.97% | 6,695,880 | $198.33M | Institution |
| Samsara Biocapital LLC | 5.84% | 5,612,896 | $166.25M | Institution |
| Kristina Burow | 5.21% | 5,004,399 | $148.23M | Insider |